Nausea, diarrhea, and constipation affect significant percentages of users during dose escalation
Using plasma concentrations uncorrected for endogenous levocarnitine, the mean distribution half life was 0.585 hours and the mean apparent terminal elimination half life was 17.4 hours
CrossRef Maternal obesity and the metabolic syndrome in reproductive health: assessing incretin-based interventions Luisa Wallentowitz, Mariana G Garcia, Catalina Atorrasagasti, Charlotte Harms, Evelyn A Huhn, Pia Roser, Stefan Verlohren, Emma M Giesen, Sandra M Blois Reviews in Endocrine and Metabolic Disorders.2026
Geographic location contributes to discrepancies in the cost of tirzepatide, as costs can differ across regions